Bookmark
Forward
Osimertinib in EGFR-Mutated Lung Cancer. Reply.
Roy S Herbst, Yi-Long Wu, Masahiro Tsuboi
The New England journal of medicine 2021 Feb 18
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Roy S Herbst, Yi-Long Wu, Masahiro Tsuboi.
Osimertinib in EGFR-Mutated Lung Cancer. Reply.
The New England journal of medicine.
2021 Feb 18;384(7):675-676
Mesh Tags
Acrylamides
Aniline Compounds
ErbB Receptors
Humans
Lung Neoplasms
Substances
Acrylamides
Aniline Compounds
osimertinib
EGFR protein, human
ErbB Receptors
PMID: 33596365
View Full Text